RESOURCE UTILISATION RELATED TO URINARY TRACT INFECTIONS IN SWEDISH SELF-CATHETERISATION PATIENTS

Author(s)

Löfroth E1, Bruce S1, Knutsson B2, Börstell T2, Myrén KJ11IMS Health, Stockholm, Sweden, 2AstraTech, Mölndal, Sweden

OBJECTIVES: To collect real-life data on costs and resource use, in order to understand the economic burden of urinary tract infection (UTI) amongst a population who has received self- catheterisation training. METHODS: We used the CEBRxA database, which combines data from a public claims database for the South-West region of Sweden, comprising around 1.5 million individuals, with national Swedish registers on drug utilisation and mortality. We identified a population of patients who had received self-catheterisation training anytime between 2006 and 2009(procedure code GB005). UTIs were identified through the following ICD-10 codes: N11.0, N30*, N39.0*, N39.X*, N12.-P, and N30.-P. A cost per UTI was calculated through considering UTI-related care contacts that occurred within 14 days from each other. RESULTS: We identified 989 patients, with a high mean age at index of 65 years, 79% males, and an average follow-up time of 1.5 years.  The disease burden of this population was mainly related to the genitourinary system, like retention of urine, benign prostate hyperplasia, cystitis, and neurogenic bladder, although essential hypertonia emerged as the third most common comorbidity. We observed an average frequency of one UTI every two years, while around one-fifth of patients had a yearly UTI-frequency of one or above. A majority of UTIs were handled in primary care, while around 80% of costs were contributed by UTI-related hospitalisations. However, among female patients, inpatient care only contributed to 60% of total costs. The mean cost per UTI was 10,500 SEK, while estimates varied, with average costs ranging from 2,100 SEK in primary care, to 32,000 SEK for inpatient care. CONCLUSIONS: Patients having received self-catheterisation training were on average of higher age and male. UTI-related hospitalisation was a clear driver of costs, although this effect was less pronounced for women.

Conference/Value in Health Info

2011-11, ISPOR Europe 2011, Madrid, Spain

Value in Health, Vol. 14, No. 7 (November 2011)

Code

PMD55

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Urinary/Kidney Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×